Botulinum toxins are potent neuromuscular blocking agents that are useful in treating various focal muscle spastic disorders and excessive muscle contractions, such as dystonia, spasms, and twitches.
As announced by CMS on April 23, providers using a third-party vendor to conduct their beneficiary eligibility transactions must attest to their relationship via the HIPAA Eligibility Transaction System (HETS) EDI Enrollment Tool by May 11.…